Phelcom proudly introduces the Eyer2, a versatile visual examination platform that delivers high-quality imaging of both the posterior and anterior segments.

This new equipment offers color and red-free fundus imaging with a new 55º field of view, along with tools for anterior segment imaging using various light sources, including cobalt blue light for corneal lesion assessment and infrared light for meibography.

The launch in Brazil took place at the North-Northeast Ophthalmology Congress (CNNO), in Maceió (AL), and at Refrativa R.I.O 2024, in Rio de Janeiro (RJ). In the United States, Eyer2 was introduced to the market at the Optometry’s Meeting held in Nashville, Tennessee, in June.

“The Eyer2 represents a new standard in portable ophthalmic devices. With this product, we aim to solidify our market leadership, expand our reach to more eye care professionals, and address diverse areas of ophthalmology. By doing so, we positively impact the vision health of a broader population, aligning with our company’s mission,” says Diego Lencione, Co-Founder and CTO of Phelcom.

Innovations and key features

The Eyer2 introduces several advancements that enhance clinical practice. “Notably, we’ve expanded the Instantaneous Field of View (FOV) for retinal images from 45º to 55º, improved image quality, and added an anterior segment module. This allows for high-resolution photo documentation of the ocular and periocular surfaces under various lighting conditions,” Lencione explains.

A diabetic retinopathy focused clinical study conducted by Phelcom with the Eyer2 revealed that the temporal retina region was frequently underrepresented. Now, in a single image, a larger area of the retina can be captured making it easier to identify lesions.

Infrared imaging with Eyer2 is a powerful tool for detecting choroidal abnormalities, such as nevi, by penetrating deeper into the eye’s posterior structures. Additionally, the device excels in performing meibography, crucial for diagnosing dry eye —a condition affecting millions globally.

The Eyer2 is designed for robustness and ease of use, featuring a magnetically connected slit lamp adapter. “Conditions like keratitis, corneal ulcers, foreign bodies, and pterygium, which are easily identified with a slit lamp, can now be documented and shared with patients or used for clinical follow-up,” adds Lencione.

The Eyer2 also supports one-click visual exams that take only seconds to complete and integrates seamlessly with the EyerCloud connection platform. Additionally, Eyer2 can be equipped with EyerMaps artificial intelligence to highlight potential retinal abnormalities.

“The magnetized anterior segment module produces incredible anterior images”

Ophthalmologist Fernando Korn Malerbi, who has utilized Eyer since 2020 in his practice, hospitals, outreach programs, and research—such as the diabetic retinopathy screening results presented at ARVO 2023 in the United States—was invited by Phelcom to test Eyer2.

“My experience with Eyer2 has been outstanding. The image quality represents a significant leap from the original version, which was already impressive,” says Malerbi.

He also praises the new features, including the ease of attaching the charging base and peripherals. “The magnetized module captures incredible images of the anterior segment and is easy to attach to Eyer2.”

Among the cases documented with the new device, Malerbi recalls a suspected neoplasm. “I sent the image to a colleague specializing in this area, and he immediately scheduled a consultation with the patient,” he shares.

Eyer2

The Eyer2 platform is a game-changer in clinical practice, offering streamlined examinations, comprehensive diagnostic capabilities, and powerful technological tools that enhance patient care.

Key Features Include:

• Single-click registration
• Ergonomic design for enhanced comfort during examinations
• Portable imaging platform offering six distinct recording modalities, without the need for pupil dilation
• High-quality 55° color fundus imaging for detecting peripheral retinal lesions;
• Instant red-free imaging following color capture
• Posterior segment imaging with infrared light, crucial for assessing deeper retinal areas without patient discomfort, such as choroidal nevus and evaporative dry eye
• #D effect of the optic disc
• Panoramic retinal image up to 120°
• High-definition documentation of the ocular surface for disease monitoring
• Cobalt blue light for corneal lesion assessment
• Portability for use in various clinical settings, remote areas, and for bedridden or neonatal patients
• Seamless integration with EyerMaps, an AI-driven tool that highlights potential retinal anomalies in seconds
• Connectivity with EyerCloud, an online platform for managing examinations.

About Phelcom

Phelcom Technologies is a Brazilian medtech company based in São Carlos, in the interior area of São Paulo. The company’s story began in 2016, when three young researchers – a physicist, an electronics engineer and a computer engineer (physics, electronics, computing) – created a portable fundus camera integrated with a smartphone.

The first prototype project was born from partner Diego Lencione’s interest in visual health, as his brother has a condition that has severely compromised his retina and vision since childhood.

In 2019, Phelcom launched its first product on the Brazilian market: the Eyer portable fundus camera. Today, the technology has reached more than two million people throughout Brazil and in the countries where it is present and has been used in  more than 100 community screenings.